- Home
- DRCT vs EDSA Comparison
DRCT vs EDSA Comparison
Compare DRCT & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- EDSA
- Stock Information
- Founded
- DRCT 2018
- EDSA 2015
- Country
- DRCT United States
- EDSA Canada
- Employees
- DRCT N/A
- EDSA N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- DRCT Technology
- EDSA Health Care
- Exchange
- DRCT Nasdaq
- EDSA Nasdaq
- Market Cap
- DRCT 16.7M
- EDSA 13.8M
- IPO Year
- DRCT 2022
- EDSA N/A
- Fundamental
- Price
- DRCT $0.55
- EDSA $2.18
- Analyst Decision
- DRCT Strong Buy
- EDSA Strong Buy
- Analyst Count
- DRCT 1
- EDSA 2
- Target Price
- DRCT $6.00
- EDSA $13.00
- AVG Volume (30 Days)
- DRCT 153.1K
- EDSA 22.9K
- Earning Date
- DRCT 05-06-2025
- EDSA 08-08-2025
- Dividend Yield
- DRCT N/A
- EDSA N/A
- EPS Growth
- DRCT N/A
- EDSA N/A
- EPS
- DRCT N/A
- EDSA N/A
- Revenue
- DRCT $48,170,000.00
- EDSA N/A
- Revenue This Year
- DRCT $50.71
- EDSA N/A
- Revenue Next Year
- DRCT $26.31
- EDSA N/A
- P/E Ratio
- DRCT N/A
- EDSA N/A
- Revenue Growth
- DRCT N/A
- EDSA N/A
- 52 Week Low
- DRCT $0.44
- EDSA $1.55
- 52 Week High
- DRCT $6.59
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- DRCT 44.03
- EDSA 60.86
- Support Level
- DRCT $0.53
- EDSA $1.89
- Resistance Level
- DRCT $0.63
- EDSA $2.23
- Average True Range (ATR)
- DRCT 0.05
- EDSA 0.11
- MACD
- DRCT -0.00
- EDSA 0.02
- Stochastic Oscillator
- DRCT 12.67
- EDSA 85.29
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.